Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Regeneron Pharmaceutical (REGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 49,039,016
  • Shares Outstanding, K 106,290
  • Annual Sales, $ 4,860 M
  • Annual Income, $ 895,520 K
  • 36-Month Beta 1.40
  • Price/Sales 10.08
  • Price/Cash Flow 45.89
  • Price/Book 10.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
360.00 +27.17%
on 04/27/17
464.40 -1.42%
on 05/22/17
+85.89 (+23.09%)
since 04/24/17
3-Month
359.93 +27.20%
on 02/27/17
464.40 -1.42%
on 05/22/17
+96.81 (+26.82%)
since 02/24/17
52-Week
325.35 +40.72%
on 11/04/16
464.40 -1.42%
on 05/22/17
+60.12 (+15.12%)
since 05/24/16

Most Recent Stories

More News
Theravance/Mylan Presents Phase III Data on COPD Candidate

Theravance Biopharma, Inc. (TBPH) and partner Mylan recently announced the presentation of additional efficacy and safety data from two pivotal phase III studies evaluating its key pipeline candidate,...

TBPH : 36.81 (+0.77%)
MYL : 39.18 (-1.04%)
VVUS : 1.08 (-3.57%)
REGN : 457.50 (-0.84%)
Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with Relapsing Multiple Sclerosis

Upcoming AWS Coverage on Regeneron Pharmaceuticals Post-Earnings Results

CELG : 117.52 (+0.18%)
REGN : 457.50 (-0.84%)
CELGZ : 1.15 (-2.37%)
Charter's Rutledge, CBS's Moonves among highest-paid CEOs

Here are the 10 highest-paid CEOs for 2016, as calculated by The Associated Press and Equilar, an executive data firm.

ATVI : 58.25 (+0.78%)
WYNN : 123.55 (-0.48%)
CHTR : 328.34 (+3.00%)
REGN : 457.50 (-0.84%)
DISCA : 25.34 (-1.13%)
SmarTrend Watching for Potential Pullback in Shares of Regeneron Pharmaceuticals After 3.18% Gain

Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $448.39 to a high of $464.39. Yesterday, the shares gained 3.2%, which took the trading range above the...

REGN : 457.50 (-0.84%)
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose

Merck & Co., Inc. (MRK) recently announced that the 600 mg film-coated formulation of its marketed drug, Isentress (raltegravir) in combination with other anti-retroviral therapies, has received positive...

VVUS : 1.08 (-3.57%)
MRK : 64.96 (+0.64%)
GILD : 64.35 (-0.53%)
REGN : 457.50 (-0.84%)
Compugen (CGEN) Worth a Look: Stock Adds 10.4% in Session

Compugen Ltd. (CGEN) shares rose over 10% in the last trading session.

CGEN : 5.25 (-0.94%)
REGN : 457.50 (-0.84%)
Regeneron, Nuance Communications, Waste Management, Waste Connections and Republic Services highlighted as Zacks Bull and Bear of the Day

Regeneron, Nuance Communications, Waste Management, Waste Connections and Republic Services highlighted as Zacks Bull and Bear of the Day

NUAN : 18.80 (-0.11%)
WCN : 92.95 (+0.58%)
WM : 71.32 (+0.42%)
RSG : 62.39 (+0.05%)
REGN : 457.50 (-0.84%)
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal

Quite a few deals were announced this week including by companies like Biogen (BIIB).

SGMO : 8.10 (-1.22%)
AKBA : 14.13 (+1.29%)
VRTX : 117.84 (+1.07%)
IONS : 46.59 (+3.21%)
REGN : 457.50 (-0.84%)
ALXN : 101.80 (-2.71%)
BIIB : 253.42 (+2.14%)
Bull of the Day: Regeneron (REGN)

Bull of the Day: Regeneron (REGN)

REGN : 457.50 (-0.84%)
SNY : 49.14 (+0.14%)
Bull of the Day: Regeneron (REGN)

Bull of the Day: Regeneron (REGN)

REGN : 457.50 (-0.84%)
SNY : 49.14 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM....

See More

Support & Resistance

2nd Resistance Point 466.93
1st Resistance Point 464.15
Last Price 457.50
1st Support Level 458.69
2nd Support Level 456.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.